Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

This study has been completed.
Information provided by (Responsible Party):
Sílvia Gel, Germans Trias i Pujol Hospital Identifier:
First received: August 25, 2009
Last updated: January 23, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):